These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8283183)

  • 1. Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C.
    Reichard O; Yun ZB; Sönnerborg A; Weiland O
    J Med Virol; 1993 Oct; 41(2):99-102. PubMed ID: 8283183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin.
    Tong MJ; Hwang SJ; Lefkowitz M; Lee SD; Co RL; Conrad A; Schmid P; Lo KJ
    J Gastroenterol Hepatol; 1994; 9(6):587-91. PubMed ID: 7865717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment.
    Weiland O; Zhang YY; Widell A
    Scand J Infect Dis; 1993; 25(1):25-30. PubMed ID: 8384732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
    Di Bisceglie AM; Conjeevaram HS; Fried MW; Sallie R; Park Y; Yurdaydin C; Swain M; Kleiner DE; Mahaney K; Hoofnagle JH
    Ann Intern Med; 1995 Dec; 123(12):897-903. PubMed ID: 7486483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
    Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.
    Dusheiko G; Main J; Thomas H; Reichard O; Lee C; Dhillon A; Rassam S; Fryden A; Reesink H; Bassendine M; Norkrans G; Cuypers T; Lelie N; Telfer P; Watson J; Weegink C; Sillikens P; Weiland O
    J Hepatol; 1996 Nov; 25(5):591-8. PubMed ID: 8938532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
    Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
    J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
    Blatt LM; Tong MJ; McHutchison JG; Russell J; Schmid P; Conrad A
    J Interferon Cytokine Res; 1998 Feb; 18(2):75-80. PubMed ID: 9506457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
    Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
    Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies.
    Urganci N; Gulec S; Dogan S; Nuhoglu A
    Int J Infect Dis; 2006 Nov; 10(6):453-7. PubMed ID: 17000127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
    Basso M; Giannini EG; Torre F; Blanchi S; Savarino V; Picciotto A
    Hepatology; 2009 May; 49(5):1442-8. PubMed ID: 19350657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.
    Bini EJ; Mehandru S
    Aliment Pharmacol Ther; 2006 Mar; 23(6):777-85. PubMed ID: 16556180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon.
    Camps J; García N; Riezu-Boj JI; Civeira MP; Prieto J
    J Hepatol; 1993 Nov; 19(3):408-12. PubMed ID: 8151102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients.
    Liu CJ; Chen PJ; Lai MY; Kao JH; Jeng YM; Chen DS
    Hepatology; 2003 Mar; 37(3):568-76. PubMed ID: 12601355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels.
    Calleja JL; García-Samaniego J; Ruiz-Antorán B; Trapero M; Morillas R; de la Revilla J; Erdozaín JC; Espinosa MD; Suárez D; Solá R; Romero-Gómez M; Baños F; Alvarez MA;
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1705-10. PubMed ID: 22742958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
    Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
    J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
    Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
    Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease.
    Kurosaki M; Enomoto N; Sato C; Sakamoto N; Hoshino Y; Haritani H; Marumo F
    J Med Virol; 1993 Mar; 39(3):246-50. PubMed ID: 7682256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.